Technische Daten
Status:In Vitro Diagnostic Use (IVD)
Ig Unterklasse:IgG
Immunogen:Synthetic peptide of human GLUT1
Vorbehandlung:ProTaqs® Antigen Enhancer I (Cat. No. 401602092)
Zelluläre Lokalisation:Membranous, cytoplasmic may be observed
Kontrolle:Erythocytes, colorectal carcinoma, malignant mesothelioma
Change(s) made:Complete revision
Synonyme:Glucose Transporter GLUT1, GT-1, GLUT-1, GLUT 1, Solute carrier family 2, facilitated glucose transporter member 1, Glucose transporter type 1, erythrocyte/brain, DYT17, DYT18, , Erythrocyte/brain HepG2 glucose transporter, Erythrocyte/hepatoma glucose transporter, Glucose transporter 1, Glucose transporter type 1, Glucose transporter type 1 erythrocyte/brain, Glucose transporter type 1, erythrocyte/brain, GLUT, GLUT1, GLUT1DS, GLUTB, GT1, GTG1, Gtg3, GTR1_HUMAN, HepG2 glucose transporter, MGC141895, MGC141896, PED, RATGTG1, SLC2A 1, SLC2A1, Solute carrier family 2 (facilitated glucose transporter), member 1, Solute carrier family 2 facilitated glucose transporter member 1.
Verfügbar in folgenden Ländern:worldwide

Glucose transporters are a wide group of membrane proteins that facilitate the transport of glucose over a plasma membrane. GLUT1 is a membrane-associated erythrocyte glucose transport protein that is a major glucose transporter in the mammalian blood-brain barrier. GLUT1 is expressed in many human tissues like colon, lung, stomach, esophagus, and breast. It is overexpressed in malignant cells and in a variety of tumors (breast, pancreas, cervix, endometrium, lung, mesothelium, colon, bladder, thyroid, bone, soft tissues, and oral cavity).